FDA Approved: BLISOVI 24 FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BLISOVI 24 FE, a combined oral contraceptive containing norethindrone acetate and ethinyl estradiol, from Lupin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• BLISOVI 24 FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for BLISOVI 24 FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)